AdaptHealth Corp. Reports Improved S&P Global Rating for Senior Unsecured Debt
S&P Global Ratings Upgrade: AdaptHealth Corp. received an upgrade from S&P Global Ratings, raising its issue-level rating on senior unsecured debt to 'BB-' from 'B+', following a $225 million prepayment of its senior secured term loan A, which enhances recovery prospects for its unsecured notes.
CEO's Statement on Financial Strategy: CEO Suzanne Foster emphasized the importance of the upgrade as recognition of the company's efforts to strengthen its balance sheet and improve financial flexibility, highlighting a $275 million reduction in term loan A funded by strong cash flow and asset dispositions.
Company Overview: AdaptHealth is a leader in healthcare-at-home solutions, providing medical equipment and services across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually through a network of 630 locations.
Forward-Looking Statements Disclaimer: The press release includes forward-looking statements that are subject to risks and uncertainties, indicating that actual results may differ from projections due to various factors, including market conditions and operational challenges.
Trade with 70% Backtested Accuracy
Analyst Views on AHCO
About AHCO
About the author
AdaptHealth to Release Q4 and Full Year 2025 Financial Results
- Earnings Release Schedule: AdaptHealth is set to announce its fourth quarter and full year 2025 financial results before the market opens on February 24, 2026, which is expected to provide investors with critical financial data and updates on business activities.
- Teleconference Details: Management will host a teleconference at 8:30 a.m. ET to discuss the financial results, with investors able to participate by dialing (833) 316-2483 (Domestic) or (785) 838-9284 (International), ensuring transparency of information.
- Webcast Replay Availability: Following the live call, a replay will be available for six months on the company's website under the 'Investor Relations' section, facilitating access for investors who could not attend in real-time and enhancing engagement with stakeholders.
- Business Overview: AdaptHealth is a leading provider of patient-centered healthcare-at-home solutions, serving approximately 4.3 million patients through a network of about 640 locations across 47 states, offering services in four key segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, demonstrating significant market influence.
Significant Monday Options Trading: ADBE, PHM, AHCO
PulteGroup Inc Options Activity: PulteGroup Inc (PHM) has seen a significant options trading volume of 11,071 contracts today, equating to about 1.1 million underlying shares, which is 68.9% of its average daily trading volume over the past month. Notably, the $85 strike call option expiring on December 19, 2025, has recorded 3,680 contracts traded.
AdaptHealth Corp Options Activity: AdaptHealth Corp (AHCO) reported an options trading volume of 6,368 contracts, representing approximately 636,800 underlying shares, or 60.6% of its average daily trading volume. The $10 strike put option expiring on January 16, 2026, has seen particularly high activity with 6,012 contracts traded.
Halper Sadeh Investigates AdaptHealth Officers for Potential Fiduciary Breach
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers of AdaptHealth Corp. breached their fiduciary duties, which could impact corporate governance and shareholder rights.
- Legal Relief Options: Long-term shareholders of AdaptHealth may seek corporate governance reforms, fund recovery, or court-approved financial incentives, aimed at enhancing transparency and accountability within the company.
- Importance of Participation: Shareholder involvement can improve company policies and oversight mechanisms, thereby enhancing shareholder value and promoting more effective management practices.
- Fee Arrangement: The law firm will handle the case on a contingent fee basis, meaning shareholders will not incur upfront legal costs, thus reducing the financial burden of participation.
Significant Wednesday Options Trading: NLOP, MSM, AHCO
MSC Industrial Direct Options Activity: MSC Industrial Direct Co Inc (MSM) has seen a significant options volume of 15,048 contracts today, equating to 1.5 million underlying shares, which is 235.9% of its average daily trading volume.
High Volume Put Option for MSM: The $80 strike put option expiring on January 16, 2026, has particularly high activity, with 5,042 contracts traded, representing about 504,200 underlying shares.
AdaptHealth Corp Options Activity: AdaptHealth Corp (AHCO) has recorded an options volume of 12,117 contracts today, amounting to 1.2 million underlying shares, or 104.9% of its average daily trading volume.
High Volume Call Option for AHCO: The $10 strike call option expiring on January 16, 2026, is notably active, with 6,065 contracts traded, representing approximately 606,500 underlying shares.
AdaptHealth to Participate in BofA Securities Leveraged Finance Conference, Showcasing Healthcare Services
- Conference Participation: AdaptHealth will participate in the BofA Securities Leveraged Finance Conference on December 2, 2025, in Boca Raton, FL, featuring a fireside chat at 8:10 a.m. ET, highlighting its leadership in healthcare services.
- Business Overview: The company focuses on patient-centered healthcare-at-home solutions across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, reaching approximately 4.2 million patients annually across all 50 states.
- Network Advantage: AdaptHealth operates around 630 locations and leverages a diversified referral network, including acute care hospitals and sleep labs, ensuring efficient delivery of medical equipment and related services to patients.
- Market Positioning: By servicing beneficiaries of Medicare, Medicaid, and commercial insurance, the company addresses complex medical needs, further solidifying its competitive edge in the home healthcare market.
Biotech and Healthcare Stocks Top After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO
Biotech Gains in After-Hours Trading: Several small- and mid-cap biotech and healthcare companies saw significant gains in after-hours trading, driven by corporate updates and financing developments.
SeaStar Medical's Leadership Change: SeaStar Medical's stock rose nearly 10% after the appointment of Michael Messinger as Chief Financial Officer, boosting investor confidence despite no new news.
Cognition Therapeutics' Speculative Buying: Cognition Therapeutics rebounded almost 11% in after-hours trading, likely due to speculative buying interest, following a decline during regular trading hours.
Mesoblast's Revenue Projection: Mesoblast's shares increased after management projected over $30 million in gross revenue for the December quarter, indicating strong demand for its cell therapy product, Ryoncil.
AdaptHealth to Release Q4 and Full Year 2025 Financial Results
- Earnings Release Schedule: AdaptHealth is set to announce its fourth quarter and full year 2025 financial results before the market opens on February 24, 2026, which is expected to provide investors with critical financial data and updates on business activities.
- Teleconference Details: Management will host a teleconference at 8:30 a.m. ET to discuss the financial results, with investors able to participate by dialing (833) 316-2483 (Domestic) or (785) 838-9284 (International), ensuring transparency of information.
- Webcast Replay Availability: Following the live call, a replay will be available for six months on the company's website under the 'Investor Relations' section, facilitating access for investors who could not attend in real-time and enhancing engagement with stakeholders.
- Business Overview: AdaptHealth is a leading provider of patient-centered healthcare-at-home solutions, serving approximately 4.3 million patients through a network of about 640 locations across 47 states, offering services in four key segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, demonstrating significant market influence.
Significant Monday Options Trading: ADBE, PHM, AHCO
PulteGroup Inc Options Activity: PulteGroup Inc (PHM) has seen a significant options trading volume of 11,071 contracts today, equating to about 1.1 million underlying shares, which is 68.9% of its average daily trading volume over the past month. Notably, the $85 strike call option expiring on December 19, 2025, has recorded 3,680 contracts traded.
AdaptHealth Corp Options Activity: AdaptHealth Corp (AHCO) reported an options trading volume of 6,368 contracts, representing approximately 636,800 underlying shares, or 60.6% of its average daily trading volume. The $10 strike put option expiring on January 16, 2026, has seen particularly high activity with 6,012 contracts traded.
Halper Sadeh Investigates AdaptHealth Officers for Potential Fiduciary Breach
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers of AdaptHealth Corp. breached their fiduciary duties, which could impact corporate governance and shareholder rights.
- Legal Relief Options: Long-term shareholders of AdaptHealth may seek corporate governance reforms, fund recovery, or court-approved financial incentives, aimed at enhancing transparency and accountability within the company.
- Importance of Participation: Shareholder involvement can improve company policies and oversight mechanisms, thereby enhancing shareholder value and promoting more effective management practices.
- Fee Arrangement: The law firm will handle the case on a contingent fee basis, meaning shareholders will not incur upfront legal costs, thus reducing the financial burden of participation.
Significant Wednesday Options Trading: NLOP, MSM, AHCO
MSC Industrial Direct Options Activity: MSC Industrial Direct Co Inc (MSM) has seen a significant options volume of 15,048 contracts today, equating to 1.5 million underlying shares, which is 235.9% of its average daily trading volume.
High Volume Put Option for MSM: The $80 strike put option expiring on January 16, 2026, has particularly high activity, with 5,042 contracts traded, representing about 504,200 underlying shares.
AdaptHealth Corp Options Activity: AdaptHealth Corp (AHCO) has recorded an options volume of 12,117 contracts today, amounting to 1.2 million underlying shares, or 104.9% of its average daily trading volume.
High Volume Call Option for AHCO: The $10 strike call option expiring on January 16, 2026, is notably active, with 6,065 contracts traded, representing approximately 606,500 underlying shares.
AdaptHealth to Participate in BofA Securities Leveraged Finance Conference, Showcasing Healthcare Services
- Conference Participation: AdaptHealth will participate in the BofA Securities Leveraged Finance Conference on December 2, 2025, in Boca Raton, FL, featuring a fireside chat at 8:10 a.m. ET, highlighting its leadership in healthcare services.
- Business Overview: The company focuses on patient-centered healthcare-at-home solutions across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, reaching approximately 4.2 million patients annually across all 50 states.
- Network Advantage: AdaptHealth operates around 630 locations and leverages a diversified referral network, including acute care hospitals and sleep labs, ensuring efficient delivery of medical equipment and related services to patients.
- Market Positioning: By servicing beneficiaries of Medicare, Medicaid, and commercial insurance, the company addresses complex medical needs, further solidifying its competitive edge in the home healthcare market.
Biotech and Healthcare Stocks Top After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO
Biotech Gains in After-Hours Trading: Several small- and mid-cap biotech and healthcare companies saw significant gains in after-hours trading, driven by corporate updates and financing developments.
SeaStar Medical's Leadership Change: SeaStar Medical's stock rose nearly 10% after the appointment of Michael Messinger as Chief Financial Officer, boosting investor confidence despite no new news.
Cognition Therapeutics' Speculative Buying: Cognition Therapeutics rebounded almost 11% in after-hours trading, likely due to speculative buying interest, following a decline during regular trading hours.
Mesoblast's Revenue Projection: Mesoblast's shares increased after management projected over $30 million in gross revenue for the December quarter, indicating strong demand for its cell therapy product, Ryoncil.
